Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 108

1.

Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child-Pugh A Liver Function: A Proof-Of-Concept Study.

Kudo M, Ueshima K, Chan S, Minami T, Chishina H, Aoki T, Takita M, Hagiwara S, Minami Y, Ida H, Takenaka M, Sakurai T, Watanabe T, Morita M, Ogawa C, Wada Y, Ikeda M, Ishii H, Izumi N, Nishida N.

Cancers (Basel). 2019 Jul 31;11(8). pii: E1084. doi: 10.3390/cancers11081084.

2.

Intestinal dysbiosis mediates experimental autoimmune pancreatitis via activation of plasmacytoid dendritic cells.

Kamata K, Watanabe T, Minaga K, Hara A, Yoshikawa T, Okamoto A, Yamao K, Takenaka M, Park AM, Kudo M.

Int Immunol. 2019 Jul 9. pii: dxz050. doi: 10.1093/intimm/dxz050. [Epub ahead of print] No abstract available.

PMID:
31287532
3.

Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study.

Ueshima K, Nishida N, Hagiwara S, Aoki T, Minami T, Chishina H, Takita M, Minami Y, Ida H, Takenaka M, Sakurai T, Watanabe T, Morita M, Ogawa C, Hiraoka A, Johnson P, Kudo M.

Cancers (Basel). 2019 Jul 7;11(7). pii: E952. doi: 10.3390/cancers11070952.

4.

Large balloon expansion method for re-intervention after endoscopic ultrasound-guided hepaticogastrostomy for stent obstruction.

Takenaka M, Nakai A, Kudo M.

Dig Endosc. 2019 Jul 5. doi: 10.1111/den.13462. [Epub ahead of print] No abstract available.

PMID:
31273839
5.

Conversion of percutaneous transhepatic gallbladder drainage to endoscopic ultrasound-guided hepaticogastrostomy by the intentional expansion method.

Takenaka M, Kamata K, Kudo M.

Dig Endosc. 2019 Jul 4. doi: 10.1111/den.13479. [Epub ahead of print] No abstract available.

PMID:
31271677
6.

Prospective study of early chronic pancreatitis diagnosed based on the Japanese diagnostic criteria.

Masamune A, Nabeshima T, Kikuta K, Hamada S, Nakano E, Kume K, Kanno A, Sato A, Tachibana Y, Inatomi O, Yamamoto S, Ikeura T, Futagami S, Taguchi M, Hanada K, Shimizu K, Kageoka M, Saito T, Eguchi T, Kubota K, Takenaka M, Mima A, Irisawa A, Ito T, Andoh A, Inui K, Takeyama Y, Yamaue H, Okazaki K, Shimosegawa T.

J Gastroenterol. 2019 Jul 3. doi: 10.1007/s00535-019-01602-9. [Epub ahead of print]

PMID:
31270692
7.

Novel concept using a plastic stent for endoscopic ultrasound-guided hepaticogastrostomy adjusting the length according to the patient's anatomy.

Takenaka M, Minaga K, Yoshikawa T, Okamoto A, Nakai A, Omoto S, Kudo M.

Endoscopy. 2019 Jul 1. doi: 10.1055/a-0948-3630. [Epub ahead of print] No abstract available.

PMID:
31261432
8.

A novel technique for stent dysfunction after endoscopic ultrasound-guided hepaticogastrostomy with antegrade stenting.

Okamoto A, Minaga K, Takenaka M, Yoshikawa T, Kamata K, Yamao K, Kudo M.

Endoscopy. 2019 May 9. doi: 10.1055/a-0890-3220. [Epub ahead of print] No abstract available.

PMID:
31071750
9.

The IFN-α-IL-33 Axis as Possible Biomarkers in IgG4-Related Disease.

Minaga K, Watanabe T, Kamata K, Takenaka M, Yasukawa S, Kudo M.

Am J Gastroenterol. 2019 Jun;114(6):1002-1003. doi: 10.14309/ajg.0000000000000245. No abstract available.

PMID:
31058651
10.

Comparison of the Diagnostic Performance of Newly Designed 21-Gauge and Standard 22-Gauge Aspiration Needles in Patients with Solid Pancreatic Masses.

Minaga K, Yoshikawa T, Yamashita Y, Akamatsu H, Ikenouchi M, Ishii T, Matsumoto H, Iwagami H, Nakatani Y, Hatamaru K, Takenaka M, Akamatsu T, Uenoyama Y, Watanabe T, Ono K, Chiba Y, Kudo M.

Dig Dis Sci. 2019 Apr 22. doi: 10.1007/s10620-019-05624-4. [Epub ahead of print]

PMID:
31011943
11.

Contrast-enhanced harmonic endoscopic ultrasonography for evaluating the response to chemotherapy in pancreatic cancer.

Tanaka H, Kamata K, Takenaka M, Yoshikawa T, Ishikawa R, Okamoto A, Yamazaki T, Nakai A, Omoto S, Minaga K, Yamao K, Sakurai T, Watanabe T, Nishida N, Chiba Y, Kitano M, Kudo M.

Dig Liver Dis. 2019 Aug;51(8):1130-1134. doi: 10.1016/j.dld.2019.03.015. Epub 2019 Apr 19.

PMID:
31006543
12.

Usefulness of Ustekinumab for Treating a Case of Myelodysplastic Syndrome-associated Inflammatory Bowel Disease.

Kono M, Sakurai T, Okamoto K, Nagai T, Komeda Y, Kashida H, Minaga K, Kamata K, Takenaka M, Hagiwara S, Watanabe T, Nishida N, Enoki E, Inoue H, Matsumura I, Kudo M.

Intern Med. 2019 Jul 15;58(14):2029-2033. doi: 10.2169/internalmedicine.2495-18. Epub 2019 Apr 17.

13.

Clinical Safety and Efficacy of Secondary Prophylactic Pegylated G-CSF in Advanced Pancreatic Cancer Patients Treated with mFOLFIRINOX: A Single-center Retrospective Study.

Yamao K, Takenaka M, Yoshikawa T, Ishikawa R, Okamoto A, Yamazaki T, Nakai A, Omoto S, Kamata K, Minaga K, Hagiwara S, Sakurai T, Nishida N, Chiba Y, Watanabe T, Kudo M.

Intern Med. 2019 Jul 15;58(14):1993-2002. doi: 10.2169/internalmedicine.2234-18. Epub 2019 Apr 17.

14.

Risk factors for local recurrence and appropriate surveillance interval after endoscopic resection.

Komeda Y, Watanabe T, Sakurai T, Kono M, Okamoto K, Nagai T, Takenaka M, Hagiwara S, Matsui S, Nishida N, Tsuji N, Kashida H, Kudo M.

World J Gastroenterol. 2019 Mar 28;25(12):1502-1512. doi: 10.3748/wjg.v25.i12.1502.

15.

Novel sphincterotomy device that orientates blade along the axis of the bile duct in patients with Roux-en-Y anastomosis.

Takenaka M, Yoshikawa T, Okamoto A, Nakai A, Minaga K, Yamao K, Kudo M.

Endoscopy. 2019 Jun;51(6):E132-E134. doi: 10.1055/a-0858-9831. Epub 2019 Mar 25. No abstract available.

PMID:
30909306
16.

Comparison of the efficacy and safety of endoscopic ultrasound-guided choledochoduodenostomy and hepaticogastrostomy for malignant distal biliary obstruction: Multicenter, randomized, clinical trial.

Minaga K, Ogura T, Shiomi H, Imai H, Hoki N, Takenaka M, Nishikiori H, Yamashita Y, Hisa T, Kato H, Kamada H, Okuda A, Sagami R, Hashimoto H, Higuchi K, Chiba Y, Kudo M, Kitano M.

Dig Endosc. 2019 Mar 25. doi: 10.1111/den.13406. [Epub ahead of print]

PMID:
30908711
17.

Evaluation of efficacy of pancreatic juice cytology for risk classification according to international consensus guidelines in patients with intraductal papillary mucinous neoplasm; a retrospective study.

Yamakawa K, Masuda A, Nakagawa T, Shiomi H, Toyama H, Takenaka M, Sakai A, Kobayashi T, Tsujimae M, Ashina S, Yamada Y, Tanaka T, Tanaka S, Nakano R, Sato Y, Ikegawa T, Kurosawa M, Fujigaki S, Kutsumi H, Itoh T, Fukumoto T, Kodama Y.

Pancreatology. 2019 Apr;19(3):424-428. doi: 10.1016/j.pan.2019.02.013. Epub 2019 Mar 5.

PMID:
30857854
18.

Intracystic papillary neoplasm preoperatively diagnosed by high-quality cytology derived from endoscopic nasogallbladder drainage.

Hara A, Kamata K, Takenaka M, Chikugo T, Kudo M.

Gastrointest Endosc. 2019 Jun;89(6):1257-1259. doi: 10.1016/j.gie.2019.02.021. Epub 2019 Feb 26. No abstract available.

PMID:
30822418
19.

The underutilization of EUS-guided biliary drainage: Perception of endoscopists in the East and West.

Yoon WJ, Park DH, Choi JH, Jang S, Samarasena J, Lee TH, Paik WH, Oh D, Song TJ, Choi JH, Hara K, Iwashita T, Perez-Miranda M, Lee JG, Vazquez-Sequeiros E, Naitoh I, Vila JJ, Brugge WR, Takenaka M, Lee SS, Seo DW, Lee SK, Kim MH.

Endosc Ultrasound. 2019 May-Jun;8(3):188-193. doi: 10.4103/eus.eus_57_18.

20.

Efficacy and Safety of Chemotherapy Following Anti-PD-1 Antibody Therapy for Gastric Cancer: A Case of Sclerosing Cholangitis.

Kono M, Sakurai T, Okamoto K, Masaki S, Nagai T, Komeda Y, Kamata K, Minaga K, Yamao K, Takenaka M, Watanabe T, Nishida N, Kudo M.

Intern Med. 2019 May 1;58(9):1263-1266. doi: 10.2169/internalmedicine.1981-18. Epub 2019 Jan 10.

Supplemental Content

Loading ...
Support Center